ARCHIVES

Phase III Trial of ThermoDox Fails to Meet Primary Endpoint

This article is from The Cancer Letter archive.

Vol. 36 No. 2 | February 22, 2013

Download PDF Visit The Full Archive

Related Articles

FDA Adopts Plan For Drug Approval After Phase 2; Chabner Unconvinced

November 4, 1988

Response From Center Representatives In L.A. To NCI Questions Is “Frusterating,” DeVita Says

April 13, 1984

Broder Not Satisfied With Mortality STATS On Three Major Cancers

September 20, 1991

Clinton’s FY97 Budget Sees $12.4 Billion For NIH, $2.28B For NCI

March 22, 1996

Cancer Support Community Reports on Patient Experiences

October 24, 2014

In Brief: Clinton Signs FY95 Apparitions Into Law, to Seek $12 Billion Recision; NIH CUTS Likely

October 29, 1993